Liu, V. M., Othus, M., Ries, R. E., Naru, J., Pogosova-Agadjanyan, E. L., Appelbaum, F. R., … Stirewalt, D. L. (2024). Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG. In Blood (Vol. 144, pp. 4309–4309). American Society of Hematology. https://doi.org/10.1182/blood-2024-198506

Liu, Vivian M., Megan Othus, Rhonda E. Ries, Jasmine Naru, Era L. Pogosova-Agadjanyan, Frederick R. Appelbaum, Lan W. Beppu, et al. “Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG.” In Blood, 144:4309–4309. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-198506.

Liu VM, Othus M, Ries RE, Naru J, Pogosova-Agadjanyan EL, Appelbaum FR, et al. Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG. In: Blood. American Society of Hematology; 2024. p. 4309–4309.

Liu, Vivian M., et al. “Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 4309–4309. Crossref, doi:10.1182/blood-2024-198506.

Liu VM, Othus M, Ries RE, Naru J, Pogosova-Agadjanyan EL, Appelbaum FR, Beppu LW, Chauncey TR, Erba HP, Godwin JE, Fitzgibbon M, Fang M, Lee SC, Moseley AB, Radich JP, Willman CL, Wu F, Meshinchi S, Stirewalt DL. Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG. Blood. American Society of Hematology; 2024. p. 4309–4309.